Manufacturer record

Ipca Laboratories Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

11 batches manufactured by Ipca Laboratories Ltd (Sikkim) were declared Not of Standard Quality between March 2019 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: GD1225008AS, Metoclopramide Hydrochloride Tablets I.P. 10 mg (exp Jul 2028). RDTL, Hubli, Karnataka (state lab) found it not of standard quality: Assay for Metoclopramide Hydrochloride. Listed in the August 2026 alert.

Records by type

11 records linked to Ipca Laboratories Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
11Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2019 to Aug 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

11
NSQ batches since 2019
9
Products affected
Assay
Most common failure
Aug 2026
Latest alert

Flagged batches per year

2019 · 12023 · 22024 · 12025 · 22026 · 5

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Metoclopramide Hydrochloride Tablets I.P. 10 mg Batch GD1225008ASMfg Aug 2025 · Exp Jul 2028 Assay for Metoclopramide HydrochlorideAssay RDTL, Hubli, KarnatakaState lab Aug 2026
Aceclofenac 100mg, Serratiopeptidase 15mg & Paracetamol 325mg Tablets Batch FND0725001BHMfg Jan 2025 · Exp Jun 2027 The sample does not conform to claim with respect to Identification and Assay/content of Aceclofenac, Paracetamol and Serratiopeptidase activity.Assay CDL, KolkataCDSCO lab Aug 2026
Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Batch FND0825055AKMfg Dec 2025 · Exp May 2028 Identity test negative for Aceclofenac and ParacetamolOther Lucknow LabState lab Jul 2026
Aceclofenac, Paracetamol & Serratiopeptidase Tablets Batch FND0826009AKMfg Feb 2026 · Exp Jul 2028 Description Rough surface on each Tablets.Description SDFTL US Nagar,UKState lab Jun 2026
Paracetamol Tablets IP 650mg Batch GMW0825055AKMfg Oct 2025 · Exp Sep 2028 The sample received does not conform to I.P. 2022 with respect to the test for DissolutionDissolution CDTL, MumbaiCDSCO lab Mar 2026
Ceftriaxone & Sulbactam for Injection IP (Keftragard-1500) Batch KPD034021AQMfg Jul 2024 · Exp Jun 2026 MisbrandedMisbranded SDTL Raipur ChhattisgarhState lab Dec 2025
Paracetamol 250 mg & Mefenamic Acid 100 mg Suspension, 60 ml (Pacimol MF 250 Suspension) Batch INC014022RMfg Apr 2024 · Exp Mar 2026 Assay of Paracetamol and Mefenamic AcidAssay CDTL-MumbaiCDSCO lab May 2025
Aceclofenac 100 mg, Serratiopeptidas e 15 mg & Paracetamol 325 mg Tablets(ZEROD OL-SP TABLETS) Batch FND033076 ASMfg Aug 2023 · Exp Jan 2026 Identification and Assay of Aceclofenac Serratiopeptidas e and ParacetamolAssay RDTL ChandigarhCDSCO lab Sep 2024
Prednisolone Tablets IP 5 mg Batch DTB-130Mfg Jan 2022 · Exp Dec 2023 Related SubstancesRelated substances RDTL ChandigarhCDSCO lab Jan 2023
Aceclofenac 100 mg & Thiocolchicoside 4 mg Tablets (Zerodol TH 4 Tablets) Batch FXT012008ASMfg Mar 2022 · Exp Feb 2025 Identification and Assay of ThiocolchicosideAssay RDTL ChandigarhState lab Jan 2023
Atormax-20 (Atorvastatin Tablets 20 mg) Batch FVQ028029Mfg Aug 2018 · Exp Jul 2020 DissolutionDissolution CDTL MumbaiCDSCO lab Mar 2019

Batches reported as suspected spurious under this label

CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.

ProductBatchReported byFirm's replyAlert
Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SPFND072001BHRDTL, ChandigarhThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.Dec 2025
Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets ZERODOL-SP TABLETSFND0725001BHRDTL, ChandigarhThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.Dec 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.